UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Complement function in mAb-mediated cancer immunotherapy

Trends in immunology, 2004-03, Vol.25 (3), p.158-164

2004

Volltextzugriff (PDF)

Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models

The Journal of immunology (1950), 2004-07, Vol.173 (2), p.797-806

2004

Volltextzugriff (PDF)

Oral beta-glucan adjuvant therapy converts nonprotective Th2 response to protective Th1 cell-mediated immune response in mammary tumor-bearing mice

Folia histochemica et cytobiologica, 2007-01, Vol.45 (2), p.107-114

2007

Volltextzugriff (PDF)

β-Glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells

Cancer research (Chicago, Ill.), 2003-12, Vol.63 (24), p.9023-9031

2003

Volltextzugriff (PDF)

Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow

Blood, 2004-03, Vol.103 (6), p.2071-2078

2004

Volltextzugriff (PDF)

C5a-mediated leukotriene B4-amplified neutrophil chemotaxis is essential in tumor immunotherapy facilitated by anti-tumor monoclonal antibody and beta-glucan

The Journal of immunology (1950), 2005-06, Vol.174 (11), p.7050-7056

2005

Volltextzugriff (PDF)

Role of the lectin domain of Mac-1/CR3 (CD11b/CD18) in regulating intercellular adhesion

Immunologic research, 2002-01, Vol.25 (3), p.219-227

Ross, Gordon D

2002

Volltextzugriff (PDF)

Function of the Lectin Domain of Mac-1/Complement Receptor Type 3 (CD11b/CD18) in Regulating Neutrophil Adhesion

The Journal of immunology (1950), 2002-12, Vol.169 (11), p.6417-6426

2002

Volltextzugriff (PDF)

Immunobiology of the Complement System: An Introduction for Research and Clinical Medicine

Ross, Gordon D

1, 1986

Volltextzugriff (PDF)

Therapeutic intervention with complement and β-glucan in cancer

Immunopharmacology, 1999-05, Vol.42 (1-3), p.61-74

1999

Volltextzugriff (PDF)

Immunobiology of the Complement System: An Introduction for Research and Clinical Medicine

Ross, Gordon D

2014

Volltextzugriff (PDF)

Macrophage cytoskeleton association with CR3 and CR4 regulates receptor mobility and phagocytosis of iC3b-opsonized erythrocytes

Journal of leukocyte biology, 1992-02, Vol.51 (2), p.109-117

1992

Volltextzugriff (PDF)

The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells

The Journal of immunology (1950), 1999-02, Vol.162 (4), p.2281-2290

1999

Volltextzugriff (PDF)

Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells

The Journal of clinical investigation, 1996-07, Vol.98 (1), p.50-61

1996

Volltextzugriff (PDF)

Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble β-glucan

Immunopharmacology, 2000-01, Vol.46 (1), p.39-54

2000

Volltextzugriff (PDF)

Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18)

The Journal of immunology (1950), 1996-02, Vol.156 (3), p.1235-1246

1996

Volltextzugriff (PDF)

Generation of recombinant fragments of CD11b expressing the functional beta-glucan-binding lectin site of CR3 (CD11b/CD18)

The Journal of immunology (1950), 1999-06, Vol.162 (12), p.7285-7293

1999

Volltextzugriff (PDF)

Isolation and Purification of C3 from Human Plasma

Current Protocols in Immunology, 2001-05, Vol.10 (1), p.13.3.1-13.3.16

2001

Volltextzugriff (PDF)

Assays for Membrane Complement Receptors

Current Protocols in Immunology, 2001-05, Vol.10 (1), p.13.4.1-13.4.18

2001

Volltextzugriff (PDF)

Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18)

The Journal of immunology (1950), 1999-09, Vol.163 (6), p.3045-3052

1999

Volltextzugriff (PDF)

Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes

The Journal of immunology (1950), 1994-02, Vol.152 (4), p.1727-1737

1994

Volltextzugriff (PDF)

Clinical and laboratory features of patients with an inherited deficiency of neutrophil membrane complement receptor type 3 (CR3) and the related membrane antigens LFA-1 and p150,95

Journal of clinical immunology, 1986-03, Vol.6 (2), p.107-113

ROSS, G. D

1986

Volltextzugriff (PDF)

Box 1. Activation and regulation of the complement system

Trends in immunology, 2004-03, Vol.25 (3), p.158

2004

Volltextzugriff (PDF)

Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle

The Journal of immunology (1950), 1993-06, Vol.150 (11), p.5104-5113

1993

Volltextzugriff (PDF)

Oral ß-glucan adjuvant therapy converts nonprotective Th2 response to protective Th1 cell-mediated immune response in mammary tumor-bearing mice

Folia histochemica et cytobiologica, 2007-04, Vol.45 (2), p.107

2007

Volltextzugriff (PDF)

1 – 25 von 753

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(640)
Mit Volltextzugriff
(602)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(472)
Life Sciences & Biomedicine
(387)
Humans
(313)
Biological And Medical Sciences
(159)
Female
(159)
Male
(137)
Medical Sciences
(112)
Animals
(106)
Adult
(84)
Middle Aged
(78)
Aged
(60)
Physical Sciences
(59)
Fundamental And Applied Biological Sciences. Psychology
(51)
Cardiovascular System & Cardiology
(47)
Cardiac & Cardiovascular Systems
(44)
Mice
(42)
Adolescent
(40)
Biochemistry & Molecular Biology
(39)
General & Internal Medicine
(38)
Immunology
(38)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Complement function in mAb-mediated cancer immunotherapy

Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models

Oral beta-glucan adjuvant therapy converts nonprotective Th2 response to protective Th1 cell-mediated immune response in mammary tumor-bearing mice

β-Glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells

Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow

C5a-mediated leukotriene B4-amplified neutrophil chemotaxis is essential in tumor immunotherapy facilitated by anti-tumor monoclonal antibody and beta-glucan

Role of the lectin domain of Mac-1/CR3 (CD11b/CD18) in regulating intercellular adhesion

Function of the Lectin Domain of Mac-1/Complement Receptor Type 3 (CD11b/CD18) in Regulating Neutrophil Adhesion

Immunobiology of the Complement System: An Introduction for Research and Clinical Medicine

Therapeutic intervention with complement and β-glucan in cancer

Immunobiology of the Complement System: An Introduction for Research and Clinical Medicine

Macrophage cytoskeleton association with CR3 and CR4 regulates receptor mobility and phagocytosis of iC3b-opsonized erythrocytes

The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells

Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells

Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble β-glucan

Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18)

Generation of recombinant fragments of CD11b expressing the functional beta-glucan-binding lectin site of CR3 (CD11b/CD18)

Isolation and Purification of C3 from Human Plasma

Assays for Membrane Complement Receptors

Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18)

Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes

Clinical and laboratory features of patients with an inherited deficiency of neutrophil membrane complement receptor type 3 (CR3) and the related membrane antigens LFA-1 and p150,95

Box 1. Activation and regulation of the complement system

Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle

Oral ß-glucan adjuvant therapy converts nonprotective Th2 response to protective Th1 cell-mediated immune response in mammary tumor-bearing mice

Suchergebnisse filtern